Price Band fixed at Rs960 per equity share of face value of Rs10 each to Rs1008 per equity share of the face value of Rs10 each
FinTech BizNews Service
Mumbai, June 28, 2024: Emcure Pharmaceuticals Limited (the “Company”) proposes to open its initial public offering of Equity Shares (“Offer”) on Wednesday, July 03, 2024. The Anchor Investor Bid/Offer Period is one Working Day prior to Bid/Offer Opening Date, that is, Tuesday, July 02, 2024. Bid/ Offer Closing Date will be on Friday, July 05, 2024.
The Price Band of the Offer has been fixed from Rs 960 per Equity Share to Rs 1008 per Equity Share. Bids can be made for a minimum of 14 Equity Shares and multiples of 14 Equity Shares thereafter.
The IPO includes a fresh share sale of Rs8 Billion and an offer for sale (OFS) of 1.14 crore equity shares by the promoters and existing shareholders. Emcure Pharmaceuticals is aiming to raise total Rs1951.04 crore through the issue.
The Company proposes to utilize the net proceeds towards repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the Company and general corporate purposes.
The Equity Shares offered through the Red Herring Prospectus are proposed to be listed on both BSE Limited (“BSE") and the National Stock Exchange of India Limited (“NSE”, together with BSE, the “Stock Exchanges”).
Kotak Mahindra Capital Company Limited, Axis Capital Limited, Jefferies India Private Limited, and J.P. Morgan India Private Limited are the Book Running Lead Managers to the Offer.
